Report overview
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
This report aims to provide a comprehensive presentation of the global market for Infectious Diseases Molecular Diagnostics Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Diseases Molecular Diagnostics Kit. This report contains market size and forecasts of Infectious Diseases Molecular Diagnostics Kit in global, including the following market information:
Global Infectious Diseases Molecular Diagnostics Kit Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Infectious Diseases Molecular Diagnostics Kit market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Polymerase Chain Reaction PCR Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Infectious Diseases Molecular Diagnostics Kit include Roche, Qiagen, Illumina, Abbott, Hologic, BioMerieux, Danaher (Cepheid), Myriad Genetics and DAAN Gene, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Infectious Diseases Molecular Diagnostics Kit companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Diseases Molecular Diagnostics Kit Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Infectious Diseases Molecular Diagnostics Kit Market Segment Percentages, by Type, 2022 (%)
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Global Infectious Diseases Molecular Diagnostics Kit Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Infectious Diseases Molecular Diagnostics Kit Market Segment Percentages, by Application, 2022 (%)
Hospital
Third-party Testing Agency
Others
Global Infectious Diseases Molecular Diagnostics Kit Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Infectious Diseases Molecular Diagnostics Kit Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Diseases Molecular Diagnostics Kit revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Infectious Diseases Molecular Diagnostics Kit revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Infectious Diseases Molecular Diagnostics Kit, market overview.
Chapter 2: Global Infectious Diseases Molecular Diagnostics Kit market size in revenue.
Chapter 3: Detailed analysis of Infectious Diseases Molecular Diagnostics Kit company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Infectious Diseases Molecular Diagnostics Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
